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OBJECTIVEdTo describe the burden of dysglycemiadabnormal glucose metabolism indic-
ative of diabetes or high risk for diabetesdamong U.S. women of childbearing age, focusing on
differences by race/ethnicity.
RESEARCH DESIGNANDMETHODSdUsing U.S. National Health and Nutrition Ex-
amination Survey data (1999–2008), we calculated the burden of dysglycemia (i.e., prediabetes
or diabetes from measures of fasting glucose, A1C, and self-report) in nonpregnant women of
childbearing age (15–49 years) by race/ethnicity status. We estimated prevalence risk ratios
(PRRs) for dysglycemia in subpopulations stratified by BMI (measured as kilograms divided
by the square of height in meters), using predicted marginal estimates and adjusting for age,
waist circumference, C-reactive protein, and socioeconomic factors.
RESULTSdBased on data from 7,162 nonpregnant women, representing .59,000,000
women nationwide, 19% (95% CI 17.2–20.9) had some level of dysglycemia, with higher crude
prevalence among non-Hispanic blacks andMexican Americans vs. non-Hispanic whites (26.3%
[95% CI 22.3–30.8] and 23.8% [19.5–28.7] vs. 16.8% [14.4–19.6], respectively). In women
with BMI ,25 kg/m2, dysglycemia prevalence was roughly twice as high in both non-Hispanic
blacks and Mexican Americans vs. non-Hispanic whites. This relative increase persisted in ad-
justed models (PRRadj 1.86 [1.16–2.98] and 2.23 [1.38–3.60] for non-Hispanic blacks and
Mexican Americans, respectively). For women with BMI 25–29.99 kg/m2, only non-Hispanic
blacks showed increased prevalence vs. non-Hispanic whites (PRRadj 1.55 [1.03–2.34] and 1.28
[0.73–2.26] for non-Hispanic blacks andMexican Americans, respectively). In women with BMI
.30 kg/m2, there was no significant increase in prevalence of dysglycemia by race/ethnicity
category.
CONCLUSIONSdOur findings show that dysglycemia affects a significant portion of U.S.
women of childbearing age and that disparities by race/ethnicity are most prominent in the
nonoverweight/nonobese.
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While national trends show that di-abetes prevalence among all U.S.adults (men and women) has risen
in recent years, seemingly concomitantly
with rates of overweight and obesity, non-
Hispanic blacks and Mexican Americans
continue to be disproportionately af-
fected, with rates almost twice those of
non-Hispanic whites (1,2). This has also
been the trend for impaired fasting glucose
(IFG), a marker of future diabetes risk
(1,2). Previous research on racial disparities
of diabetes prevalence has focused on dis-
parities for common risk factors for the dis-
ease: obesity and poverty, among others
(3,4). However,findings from these studies
show that there appears to be a residual
effect of race/ethnicity (3,4), while control-
ling for the effect of BMI and social factors,
with no concrete explanation as towhy this
might be so.
Little attention has been paid specif-
ically to investigating factors associated
with disparity in glucose levels among
women in their reproductive years. How-
ever, this proves an important population
to target, not only because of the woman’s
health needs and subsequent risk for type
2 diabetes (5), but also because of her role
as a caregiver and the potential adverse
consequences for her offspring if exposed
to gestational hyperglycemia (6–8). We
therefore conducted an analysis using
U.S. national data to describe the burden
of dysglycemiaddiabetes, IFG, or high
risk for diabetes by A1C criteriadamong
women of childbearing age, focusing spe-
cifically on differences by race/ethnicity.
We also explored the extent to which mea-
surements of obesitydmeasured by BMI




Sample population and data source
The National Health and Nutrition Ex-
amination Survey (NHANES) is an ongo-
ing national survey conducted by the
National Center for Health Statistics
(NCHS) (9). It uses a complex multistage
probability sample so as to represent the
civilian, noninstitutionalized U.S. popu-
lation. Participants of the survey complete
in-home interviews followed by medical
and laboratory examinations in mobile
examination centers. Additionally, half
of those who participate in the medical
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examination are asked to fast overnight
for laboratory testing, comprising a na-
tionally representative fasting subsample.
Our study focuses on nonpregnant fe-
males 15–49 years of age who underwent
the interview and medical and/or labora-
tory examinations of NHANES, com-
bined from five survey cycles from 1999
to 2008. Pregnancy status was by self-
report, confirmed with a laboratory test.
For fastingmeasures, we includedwomen
who were part of the morning fasting ses-
sion and excluded women from the fast-
ing subsample if their fasting times were
,8 h. The NCHS Research Ethics Review
Board approved the surveys, and docu-
mented consent was obtained from all
participants. The interview, examination,
and laboratory procedures have previ-
ously been described (9).
Study variables
Demographic variables. Demographic
information was collected on the basis of
self-report during the in-home interviews.
Race/ethnicity was categorized according
to NHANES guidelines for comparing
across survey cycles and included “non-
Hispanic white,” “non-Hispanic black,”
“Mexican American,” and “other.” We
chose not to present estimates fromwomen
in the “other” category because of the small
sample size for, and heterogeneity of, this
group. We considered age as a continuous
variable and dichotomized education at-
tainment as having completed less than
high school or having completed high
school (or the equivalent) or more. We cat-
egorized civil status as single or married/
cohabitating and the number of live births
towomen as 0, 1, 2, 3, or$ 4. The poverty-
to-income ratio (PIR)dmeasuring the ratio
of family income to the family’s appropriate
poverty thresholddwas computed by the
NCHS from the poverty threshold for the
relevant calendar year, family income, and
other family data provided by the respon-
dents tomeasure income status (9).Wepres-
ent PIR classified into three categories, as
suggested by Healthy People 2010 (10):
PIR,1 (poor), PIR$1 but,2 (near poor),
and PIR$2 (middle or high income).
Outcome variables. We defined dysgly-
cemia as any abnormality in glucose me-
tabolism, indicative of diabetes or high risk
for diabetes (IFG or elevated A1C).
Specifically, a participant was identified
as having some measure of dysglycemia if
she met any one of the following criteria:
1) During the in-home interview, she re-
sponded affirmatively to the question of
whether, outside of pregnancy, a doctor
or other health care professional had ever
told her that she had diabetes; she re-
ported taking insulin; or she reported taking
diabetes medicines. 2) Results from her
clinical examination indicated diabetes by
either an FPG value $126 mg/dL or A1C
$6.5% (48 mmol/mol) (11). Or 3) results
from her clinical examinations indicated a
high risk for diabetes by either a FPG value
between 100 and 126 mg/dL or A1C value
of 5.7–6.4% (39–46 mmol/mol) (11).
Details about collection and process-
ing of blood samples can be found in
documentation on the NHANES website
(9). Briefly, FPG was measured using a
hexokinase enzymatic method, with a co-
efficient of variation of 1.3–2.2%. To ac-
count for changes to the laboratory and
equipment used for measurement of glu-
cose in 2005–2008 versus those used for
1999–2004, we converted values from
2005 to 2008 via a linear transformation
tomake them comparablewith values from
1999 to 2004 (9). A1Cwasmeasured using
whole blood at a central laboratory by a
high-performance liquid chromatographic
assay and standardized according to the
method of the Diabetes Control and Com-
plications Trial (12), with a coefficient of
variation of 1.0–1.7% (9). We used only
A1C values from1999 to 2006 for this anal-
ysis to avoid any bias that might be intro-
duced by the inexplicable trending higher
values from 2007 to 2008 (9).
Other cardiometabolic factors and co-
variates. Height and weight were mea-
sured in the mobile examination centers
(9), and BMI was calculated as weight in
kilograms divided by the square of the
height in meters. We categorized BMI ac-
cording to World Health Organization
definitions (13) and grouped these into
three categories: under- or normal weight
(BMI ,25.0 kg/m2), overweight (25–
29.99 kg/m2), and obese or morbidly
obese ($30 kg/m2). To consider the ad-
verse metabolic effects and increased car-
diovascular mortality resulting from
greater abdominal adiposity (14,15), we
assessed waist circumference as an inde-
pendent risk factor. High central adipos-
ity was considered as waist circumference
$88 cm (16). To account for low-grade
inflammation and its potential associa-
tion with diabetes development (16), we
categorized levels of C-reactive protein
(CRP), a proinflammatorymarkermeasured
in NHANES participants, with the cut
point at 0.3 mg/dL or higher (16). CRP
concentrations were measured by latex-
enhanced nephelometry on a Behring
Nephelometer (Siemans Healthcare Di-
agnostics, Deerfield, IL).
Statistical analysis
Women were considered eligible for the
analysis if they attended themedical exam
and had complete information for race/
ethnicity status, pregnancy status, age,
education attainment, and PIR. Statistical
analyses were performed using SAS-call-
able SUDAAN, version 9.2 (SAS Institute,
Cary, NC). The five survey cycles (1999–
2000, 2001–2002, 2003–2004, 2005–
2006, and 2007–2008) were merged
into one dataset, and 10-year sampling
weights were calculated based on guide-
lines recommended byNCHS for analyses
that combine two or more survey cycles
(9). For those variables not meeting nor-
mality assumptions (i.e., number of live
births) the categorical variable was used
for analyses. All analyses incorporated the
correct sample weights for the subsample
and complex survey design. We calcu-
latedmean levels (95%CI) for continuous
variables and prevalence estimates (95%
CI) for categorical variables. SEs were es-
timated using the Taylor series lineariza-
tion method. Estimates were considered
reliable if degrees of freedom were $12
and the relative SE #30% (9). We used
fitted multiple logistic regression models
to estimate crude and adjusted odds ratios
(ORs) and prevalence risk ratios (PRRs)
with accompanying 95% CIs for our out-
come variable dysglycemia (17,18). Our
calculation of the PRR was performed as a
function of the average marginal predic-
tions from the fitted regression models
(17). We considered the following varia-
bles for confounding, based on previous
literature: age, PIR, education, number of
live births, waist circumference, and CRP.
We elected to keep the covariates stated
above in themodel if they changed the full
model OR by$10% (19). Our final mod-
els therefore adjusted for age, education,
PIR, waist circumference, and CRP. We
assessed model fit using the Hosmer-
Lemeshow goodness of fit, Satterthwaite-
adjusted F test (20). Correlation among
independent variables was assessed via
the variance inflation factor and condition
indices, using accepted criteria (20); we
found no presence of multicollinearity.
We assessed effect modification by using
fully adjusted models containing all rele-
vant two-way interaction terms; because
the interaction between race/ethnicity and
BMI was significant in our models (P ,
0.05), we present our findings stratified
on BMI category. To assess possible sample
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bias from the limited data of A1C, we
conducted a sensitivity analysis restricted
to data from 1999–2006 and arrived at
the same conclusions as for the full data-
set (1999–2008); therefore, we presented
our findings based on the full 1999–2008
dataset.
RESULTSdAfter exclusion of women
with inadequate fasting times (n = 421),
our final sample totaled 7,162 women,
with 2,950 eligible for the fasting analyses.
Women who were excluded from the anal-
ysis because of invalid fasting times did
not differ from those included in the anal-
ysis in race/ethnicity category, PIR, parity,
BMI, waist circumference, or CRP values.
We did notice that women who were ex-
cluded were slightly younger than women
included in the analysis (P , 0.05) by
~2 years (mean [SD] age for included vs.
excluded women, respectively: 29.8 [10.6]
vs. 27.8 [10.6]). Demographic characteris-
tics of the study population are provided in
Table 1. The mean age of our population
was 33 years, with Mexican American
women slightly younger than the total pop-
ulation and both non-Hispanic white and
non-Hispanic black women. Most women
surveyed in the total population were
married or cohabitating, with at least a high
school education, and had had at least one
live birth. Compared with non-Hispanic
whites, both non-Hispanic blacks and
Mexican Americans were more likely to be
near poor or below the poverty line (55.4
and 65.9 vs. 30.2%, respectively) and less
likely to have attained a high school degree
or greater (71.0 and 50.7 vs. 84.6%, respec-
tively; P, 0.01 for each comparison).
More than 50% of U.S. women of
childbearing age were overweight, obese,
or morbidly obese. Prevalence of obesity
was significantly higher in non-Hispanic
black andMexican American women com-
pared with non-Hispanic white women
(prevalence estimates: 47.0% [95% CI
44.6–49.5], 36.3% [33.1–39.6], and
28.0% [25.8–30.3] for non-Hispanic black,
Mexican American, and non-Hispanic
white women, respectively; P , 0.01 for
each comparison) (Fig. 1). Additionally,
high central adiposity (waist circumfer-
ence $88 cm) affected almost 50% of
all women in this population, with pro-
portions reaching 58% or greater for
both non-Hispanic blacks and Mexican











Age (years)† 7,162 33.1 (32.7–33.4) 33.5 (33.1–34.9) 32.6 (32.1–33.2)a 31.3 (30.8–31.8)b
Education level 7,162
,High school 2,711 21.2 (19.8–22.7) 15.4 (13.7–17.2) 29.0 (25.8–32.5)b 49. 4 (45.5–53.2)b
$High school 4,451 78.8 (77.3–80.2) 84.6 (82.8–86.3) 71.0 (67.6–74.2)b 50.7 (46.8–54.5)b
Civil status 7,069
Married/cohabitating 3,132 56.9 (55.1–58.6) 61.8 (59.8–63.8) 34.8 (32.0–37.7)b 61.1 (58.3–63.9)
PIR† 7,162 2.8 (2.7–2.9) 3.1 (3.0–3.2) 2.1 (2.0–2.2)b 1.9 (1.8–2.0)b
PIR ,1, below poverty line 1,881 18.2 (16.7–19.8) 13.0 (11.1–15.1) 29.1 (25.7–32.7)b 33.0 (29.8–36.4)b
1 # PIR , 2, near poor 1,797 20.7 (19.5–22.0) 17.2 (15.4–19.0) 26.3 (23.4–29.4)b 32.9 (30.3–35.6)b
PIR $2, middle or high income 3,484 61.1 (59.1–63.1) 69.8 (67.0–72.5) 44.6 (41.3–48.0)b 34.2 (31.2–37.0)b
Number of live births† 3,822 2.1 (2.1–2.2) 2.0 (2.0–2.1) 2.3 (2.2–2.4)b 2.5 (2.4–2.6)b
0 245 6.5 (6.1–7.8) 6.6 (6.1–8.4) 7.7 (7.0–10.2)* 3.0 (2.5–4.7)*,b
1 1,005 25.0 (23.3–26.8) 25.7 (23.2–28.3) 23.3 (20.8–25.9) 23.2 (19.9–26.8)
2 1,211 36.0 (34.1–37.8) 37.9 (35.4–40.4) 32.7 (29.5–36.0)a 27.3 (23.9–31.1)b
3 854 22.3 (20.8–23.9) 22.2 (20.2–24.3) 20.8 (17.9–23.9) 27.5 (25.0–30.3)b
$4 507 10.2 (9.0–11.6) 7.6 (6.1–9.4) 15.6 (13.3–18.3)b 19.0 (16.1–22.2)b
Cardiometabolic factors
BMI (kg/m2)† 7,027 27.6 (27.3–27.9) 27.0 (26.6–27.5) 30.7 (30.3–31.2)b 28.7 (28.2–29.1)b
BMI ,25 kg/m2
(under- or normal weight) 3,065 44.6 (42.5–46.7) 48.9 (45.9–52.0) 26.4 (24.3–28.7)b 32.8 (30.1–35.7)b
25 # BMI ,30 kg/m2
(overweight) 1,747 24.6 (23.2–26.2) 23.1 (21.3–24.9) 26.6 (24.3–29.0) 30.9 (28.7–33.2)b
BMI $30 kg/m2
(obese or morbidly obese) 2,215 30.8 (29.1–32.6) 28.0 (25.8–30.3) 47.0 (44.6–49.5)b 36.3 (33.1–39.6)b
Waist circumference (cm)† 6,900 90.5 (89.8–91.2) 89.7 (88.7–90.7) 95.8 (94.8–96.7)b 92.7 (91.8–93.6)b
$88 cm (high) 3,331 48.8 (46.7–50.9) 46.1 (43.3–48.9) 62.4 (60.1–64.6)b 58.4 (55.0–61.8)b
CRP (mg/dL)† 6,696 0.4 (0.4–0.5) 0.4 (0.4–0.4) 0.6 (0.5–0.6)b 0.5 (0.5–0.6)b
.0.3 (elevated) 2,435 37.1 (35.5–38.8) 35.4 (33.1–37.7) 44.6 (41.9–47.4)b 44.5 (41.1–47.9)b
FPG (mg/dL)† 2,950 93.3 (92.5–94.1) 92.1 (91.1–93.1) 95.2 (92.6–97.8)a 97.1 (94.8–99.5)b
A1C (%)† 5,764 5.2 (5.2–5.3) 5.2 (5.1–5.2) 5.5 (5.4–5.5)b 5.4 (5.3–5.4)b
Any level of dysglycemia
present^ 2,954 19.0 (17.2–20.9) 16.8 (14.4–19.6) 26.3 (22.3–30.8)b 23.8 (19.5–28.7)b
Data are percent (95% CI) unless otherwise indicated. ‡Unweighted n. †Mean (95% CI). aP value , 0.05 compared with non-Hispanic whites. bP value , 0.01
compared with non-Hispanic whites. *,12 df and relative SE .30%; presenting adjusted CI (9). ^Self-report of diabetes or taking diabetes medicines from the
interview, FPG $100 mg/dL, or A1C $5.7% (39 mmol/mol) from laboratory measures.
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Americans compared with 46% for non-
Hispanic whites (Table 1).
We observed higher FPG, A1C, and
CRP levels among non-Hispanic blacks
and Mexican Americans compared with
non-Hispanic whites (Table 1). Almost
20% of all nonpregnant U.S. women of
childbearing age had some measure of
dysglycemia. Higher proportions of dys-
glycemia were seen among minority
groups compared with non-Hispanic
whites: 26.3% (95% CI 22.3–30.8) in
non-Hispanic blacks and 23.8% (19.5–
28.7) in Mexican Americans vs. 16.8%
(14.4–19.6) in non-Hispanic whites.
In stratified analyses (Table 2 and
Supplementary Table 1), within normal
to underweight women, we saw higher
prevalence of dysglycemia among both
non-Hispanic black and Mexican Ameri-
can women compared with non-Hispanic
white women. For this BMI category, in
our unadjusted models, prevalence of dys-
glycemia was twice as high in both non-
Hispanic blacks and Mexican Americans
compared with non-Hispanic whites.
These observations held when models
were adjusted for age, socioeconomic fac-
tors, waist circumference, and CRP levels,
though the estimates were slightly attenu-
ated (PRRadj 1.86 [95% CI 1.16–2.98] for
non-Hispanic blacks and 2.23 [1.38–3.60]
for Mexican Americans) (Table 2). Lower
education attainment was also significantly
associated with higher prevalence of dys-
glycemia within this BMI category, as was
having a waist circumference $88 cm.
Among overweight women, we observed
that non-Hispanic blacks had ~1.5 times
the prevalence of dysglycemia compared
with non-Hispanic whites; this disparity
persisted after adjusting for age, socioeco-
nomic factors, waist circumference, and
CRP (PRRadj 1.55 [1.03–2.34]), with the
same effect for both lower education attain-
ment and waist circumference observed as
seen in the normal and underweight
women. We found no significant differen-
ces in dysglycemia prevalence between
overweight Mexican American women
and overweight non-Hispanic white
women. Additionally, among obese and
morbidly obese women, we did not ob-
serve any differences in dysglycemia by
race/ethnicity status in either crude or ad-
justed models (Fig. 2).
CONCLUSIONSdUsing nationally
representative data collected over 10 years
and representing .50 million women, we
found that almost 1 in 5 U.S. women of
childbearing age were affected by some
form of dysglycemia. Additionally, more
than one-half of all U.S. women of child-
bearing age were overweight or obese, and
nearly 50% had high central adiposity. We
also observed the disproportionate burden
of dysglycemia among racial and ethnicmi-
norities compared with non-Hispanic
whites,with prevalence estimates inminor-
ities ~1.5 times those in non-Hispanic
whites. When stratified by BMI cate-
gory, we continued to see disparities in
dysglycemia prevalence by race/ethnicity
status, though this was restricted to dis-
tinct BMI categories. Within the normal-
to-underweight group, both non-Hispanic
blacks and Mexican Americans had almost
twice the prevalence of dysglycemia versus
non-Hispanic whites. In the overweight
group, only non-Hispanic blacks had in-
creased prevalence, at almost 1.5 times
that of non-Hispanic whites.
Hyperglycemia among women of
childbearing age poses a risk not only to
the woman as she progresses through
various life stages (5) but also to her fetus
if she becomes pregnant (6–8). These ef-
fects could impact the long-term health of
her child, including increased risk of obe-
sity and type 2 diabetes later in life (21,22).
However, little attention has been paid to
diabetes and measures of dysglycemia spe-
cifically among nonpregnant women of
childbearing age. Most estimates from
U.S. data for this particular population sub-
group are derived from analyses using
broad age ranges, as well as pregnant and
nonpregnant women. Previously reported
prevalence estimates range between 3 and
7.5% for self-reported diabetes and 8 and
23% for clinicalmeasures of IFG (1,2),with
higher estimates for both measures in mi-
nority groups and higher age categories.
Our results for overall dysglycemia (which
includes diabetes and prediabetes mea-
sures, including IFG) are comparable
with these estimates, despite our younger
cohort. This is of note, since diabetes and
dysglycemia in general increase with
age (23), and highlights the importance
of focusing interventions on this younger
age-group.
Research focusing specifically on non-
diabetic women of childbearing age shows
disproportionate levels of obesity and
other clinical characteristics of the met-
abolic syndrome, including IFG, among
both non-Hispanic blacks and Hispan-
ics compared with non-Hispanic whites
(24). Since these data excluded diabetic
women, our study is the first to investi-
gate diabetes and prediabetes measures
specifically among women of childbear-
ing age. Other findings from national data
have shown variations in diabetes preva-
lence by BMI group. A recent study (25)
looking at 30 years of NHANES data
shows variation in racial/ethnic disparities
of diabetes by BMI group: in normal and
overweight individuals, minority groups
experience a greater increase in diabetes
prevalence than whites over the time pe-
riod studied, but in obese and severely obese
groups this disparity is less pronounced.
Though this recent study includes a larger
Figure 1dPrevalence of under/normal weight, overweight, and obese (by BMI cutoffs) among
nonpregnant U.S. women of childbearing age (15–49 years) for total population and by race/
ethnicity, NHANES 1999–2008. *P # 0.05 vs. non-Hispanic white. MA, Mexican American;
NHB, non-Hispanic black; NHW, non-Hispanic white.
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age-group (20–74 years old) as well as men
and women together, it corroborates some
of our observations presented here.
Diabetes has been shown to be asso-
ciated with obesity (26,27). However, in
our results we see discordance in dysgly-
cemia and obesity, with differences by race/
ethnicity among women not considered
obese by standard clinical measures. Oth-
ers before us have noted differential effects
of BMI on diabetes risk between black and
white Americans (4). This highlights the
fact that obesity, as measured by either
BMI or waist circumference, does not ex-
plain all disparities by race/ethnicity in
impaired glucose metabolism in a clinical
setting or at a population level. One pos-
sible explanation for the disparity within
nonobese subjects is a differential b-cell
function between race/ethnicity groups.
Results from clinical studies have shown
decreased insulin sensitivity in African
American women compared with Euro-
pean American women (28,29), with dif-
ferential responses by race/ethnicity in
insulin sensitivity and b-cell responsive-
ness according to level of body fat (30)
and location of body fat depots (31,32).
Although obesity alone causes a state of
insulin resistance, it is possible that the
pancreatic response is different in the
presence of adipose tissue within different
race/ethnicity groups, which may help to
explain our observation by BMI category.
We focused our attention on varia-
tions within BMI categories. However,
BMI has been criticized as a crude mea-
sure for obesity, since it does not discrim-
inate between lean muscle and body fat
and therefore might not account for in-
dividuals with normal-weight obesity (i.e.,
normal BMI but high body fat). Clin-
ical studies among women with a normal
BMI showed that as body fat increased, so
did prevalence of metabolic syndrome
and dyslipidemia (33). Furthermore,
Table 2dCrude PRRs and PRRadj (95% CI) for dysglycemia in nonpregnant U.S. women of childbearing age (15–49 years) by BMI category
2:
NHANES 1999–2008
Under- or normal-weight BMI
(n = 1,118; nweighted = 23,213,172)
Overweight BMI
(n = 640; nweighted = 12,462,018)
Obese or morbidly obese
(n = 830; nweighted = 16,222,072)
Crude model Adjusted model1 Crude model Adjusted model1 Crude model Adjusted model1
Race/ethnicity
Non-Hispanic
white Reference category Reference category Reference category Reference category Reference category Reference category
Non-Hispanic
black 1.81 (1.09–3.01) 1.86 (1.16–2.98) 1.54 (1.06–2.24) 1.55 (1.03–2.34) 0.99 (0.75–1.30) 1.06 (0.81–1.39)
Mexican American 2.12 (1.37–3.30) 2.23 (1.38–3.60) 1.41 (0.87–2.29) 1.28 (0.73–2.26) 0.94 (0.72–1.23) 0.99 (0.74–1.32)
Education
$High school Reference category Reference category Reference category
,High school 2.24 (1.34–3.77) 1.71 (1.04–2.81) 1.09 (0.87–1.36)
Waist circumference (cm)
#88 Reference category Reference category Reference category
.88 2.30 (1.21–4.38) 1.89 (1.00–3.57) 1.21 (0.30–4.80)
PIR
$Middle class Reference category Reference category Reference category
Near poor 0.76 (0.44–1.33) 1.20 (0.67–2.14) 1.00 (0.75–1.33)
Below poverty line 0.78 (0.42–1.46) 0.69 (0.30–1.63) 1.21 (0.95–1.59)
CRP (mg/dL)
#0.3 Reference category Reference category Reference category
.0.3 1.30 (0.78–2.15) 0.94 (0.60–1.48) 1.41 (1.02–1.96)
1Adjusted for age (continuous), waist circumference (,88 or $88 cm), education (,high school or $high school), PIR (,1, poor;$1 but,2, near poor; or $2,
middle or high income), and CRP (#0.3 or.0.3 mg/dL). 2Normal and underweight: BMI,25.0 kg/m2, overweight: BMI 25–29.99 kg/m2, and obese or morbidly
obese: BMI $30 kg/m2.
Figure 2dPRRadj (95% CI) for dysglycemia in different race/ethnicities in nonpregnant U.S.
women of childbearing age, stratified by BMI category. Adjusted for age (continuous), waist
circumference (,88 or$88 cm), education (,high school or$high school), PIR (,1, poor;$1
but ,2, near poor; or $2, middle or high income), and CRP (#0.3 or .0.3 mg/dL). Under or
normal weight: BMI,25.0 kg/m2 (n = 1,118; nweighted = 23,213,172); overweight: BMI 25–29.99
kg/m2 (n = 640; nweighted = 12,462,018), and obese or morbidly obese: BMI$30 kg/m
2 (n = 830;
nweighted = 16,222,072).
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among those women with normal-weight
obesity, insulin sensitivity was significantly
decreased. Additionally, the researchers
found an increased risk of cardiovascular
mortality among these women, suggesting
that classifying a person as “normal” based
on BMI alonemightmask the effects of that
person’s body fat content. However, the
body fat measures used in these clinical
studies did not account for the distribution
of fatdspecifically, the location of the fat
stores. Although visceral adipose has been
linked to increased diabetes incidence (14),
clinical studies have shown that African
Americanwomenhave less visceral adipose
stores compared with European American
women, even after periods of significant
weight gain and loss (34,35).We attempted
to account for the increased risk posed by
central adiposity by adjusting for waist
circumference category using a clinically
relevant measure and still noticed differ-
ences in dysglycemia prevalence by race/
ethnicity among women with a normal
BMI. The use of these clinical indices alone
may not identify some women at increased
risk for impaired glucose tolerance.
Differences in dysglycemia by race/
ethnicity may also be due to factors un-
related to glucose control and could be a
result of genetic or ancestral differences,
particularly related to A1C variation. Sev-
eral epidemiological studies have reported
higher A1C values in African Americans vs.
whites, independent of FPG levels (36,37).
Results from the Diabetes Prevention Pro-
gram show that among individuals with
impaired glucose tolerance, both blacks
and Hispanics had higher A1C levels than
whites, even after adjusting for cofactors
such as age, sex, education, BMI, blood
pressure, and insulin resistance (38). Pre-
vious research estimates that genetic factors
might explain .50% of variation in A1C
(39) and supports the exploration for a ge-
netic loci unique to A1C. However, recent
research from the Atherosclerosis Risk on
Communities (ARIC) study shows a small
contribution of genetic ancestry relative to
social and metabolic factors in explaining
A1C variation among African Americans,
indicating that ancestral genetic differences
might not explain significantly the ob-
served race/ethnicity differences in A1C
(40). More research is warranted to inves-
tigate the role of genetic factors in these
specific associations.
While our analysis uses robust, nation-
ally representative survey data, there are
some limitations to our study. NHANES
data are based on a cross-sectional survey;
consequently, there is no way to assess
causality. Also, because of possible dis-
closure risks, for the 2007–2008 survey
cycle only pregnancy status information
for women aged 20–44 years was avail-
able. We therefore may have missed some
nonpregnant women aged 15–19 and
45–49 years in the survey. We also re-
stricted our analyses to only three race/
ethnicity categories; small sample size
and wide heterogeneity of a fourth cate-
gory (“other”) did not allow for reliable
comparison with the other defined catego-
ries for race/ethnicity. Additionally, fasting
measures are based on one FPG value, and
fasting state is based on the participants’
self-report. For clinical diagnoses, it is rec-
ommended that the subject be retested in
the presence of an abnormal result; we
did not have this opportunity. Therefore,
it is likely that some prevalence estimates
from the use of FPG values might be over-
estimated. Also, diagnosed diabetes is by
self-report; however, we are able to use
laboratory values for diabetes measures
to help eliminate any biases of self-report.
Finally, we are missing values of A1C from
the 2007–2008 NHANES cycle. NCHS
released a statement in March 2012 noting
an increase in the proportion of A1C values
between 5.7 and 6.4% (39–48 mmol/mol)
and subsequent shift to the right (increased
values) of A1C distribution in NHANES
2007–2010 compared with 1999–2006.
However, after extensive investigation, the
specific source for this observation is cur-
rently unknown (9). Since our analyses are
focused on those persons with higher
A1Cdparticularly, 5.7% (39 mmol/mol)
and abovedinclusion of these data from
2007–2008 may have biased our results;
therefore, we chose not to include these
data in our analyses. Because of this, some
individuals may have been misclassified
on their status of dysglycemia. To test
how this might affect our results and sub-
sequent conclusions from our findings, we
conducted a sensitivity analysis using only
data from 1999–2006. We observed no sig-
nificant changes to our conclusions using
this data subset and therefore presented re-
sults from the full dataset, 1999–2008. A
breakdown of our outcome showed that
8.3% of our population were categorized as
having dysglycemia by A1C criteria, 16.2%
by FPG criteria, and 2.7% by interview re-
sponse (i.e., with diagnosed diabetes).
Within the whole study sample, 3.0% were
categorized as having dysglycemia bymeet-
ing both A1C and FPG criteria, 1.3% by
A1C criteria alone, and 8.4% by FPG crite-
ria alone. However, the fact that we were
able to include both laboratory measures
for glucose and A1C, as well as a self-report
of doctor-diagnosed diabetes, adds to the
robustness of our study.
In summary, we found that approxi-
mately one in five of the nation’s nonpreg-
nant women of childbearing age is affected
by some form of dysglycemia. This corre-
sponds to almost 9 million U.S. women
between the ages of 15 and 49 years, with
a greater burden among minorities com-
pared with non-Hispanic whites. While
our findings confirm the presence of dis-
parities in dysglycemia prevalence by race/
ethnicity, contrary to previous literature we
find this difference is explained not by obe-
sity but, rather, by differences within nor-
mal to underweight groups. These findings
suggest that special attention should be
paid specifically to the disparities among
nonobese individuals both in clinical prac-
tices and in development of public health
programs and interventions.
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